activationacuteadamts13adultadultsagingallogeneicamlamyloidosisanemiaantiantibodiesantibodyantigenaplaplasticassessmentassociatedbispecificbleedingbonecancercausescd19celcellcellschemotherapychildrenchronicclassicalclinicalcllclonalcmlcnscovidcytokinediagnoseddiagnosisdiffusediseasedisordersdlbcldonordrivesdualebveffectsfactorfailurefirstflt3follicularfunctiongenegenomicgermlinegvhdhaploidenticalhcthematologichematopoiesishematopoietichemoglobinhemophiliahereditaryhighhlhhodgkinhomeostasishschscthumanhydroxyureaibrutinibimmuneimmunityimpactinducedinductioninfectioninflammationinhibitioninhibitorinhibitorsinsightsironitplandscapelargelenalidomideleukemialeukemiaslinelonglosslymphoblasticlymphomalymphomasmacrophagemaintenancemalignanciesmalignancymantlemarrowmclmdsmechanismsmicrobiotamicroenvironmentmmmodelmolecularmonoclonalmrdmultiplemutantmutatedmutationsmyelodysplasticmyelofibrosismyeloidmyelomanegativeneoplasmsneutrophilnewlynknovelnpm1obinutuzumabolderoutcomespatientspdpediatricpembrolizumabplateletplateletspluspositivepostpreventionprimaryprognosticpromotesprophylaxisrarerealreceptorrefractoryrelapserelapsedrelatedresistanceresponsereviewriskrituximabrnaroleruxolitinibscdseasonseriesseveresicklesignalingspecificstemstratificationstrokesyndromesyndromestargetedtargetingtermthalassemiatherapythrombocytopeniathrombosisthrombotictp53transplanttransplantationtreattreatmenttrialttptypeusingvaccinationvariantsvenetoclaxversusvexasvtevwfwillebrand